Business Description
Medicenna Therapeutics Corp. is a Toronto-based medical company focused on developing new treatments for cancer, inflammation, and immune-related diseases. Its lead drug candidate targets recurrent glioblastoma, an aggressive form of brain cancer, while its broader pipeline includes therapies designed to strengthen the immune system's ability to fight tumors and others aimed at calming harmful immune responses in conditions like multiple sclerosis. The company's approach centers on engineering enhanced versions of naturally occurring immune proteins to improve their precision and effectiveness.
